This trial will investigate whether glutathione (GSH) precursors N-acetylcysteine and glycine can help improve cognition in humans with mild cognitive impairment.
- Mild Cognitive Impairment
1 Primary · 5 Secondary · Reporting Duration: Change between 0-weeks and 12-weeks
2 Treatment Groups
1 of 2
1 of 2
60 Total Participants · 2 Treatment Groups
Primary Treatment: MCI-active · Has Placebo Group · Phase < 1
Who is running the clinical trial?
Age 55 - 85 · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is this investigation recruiting individuals aged 35 and over?
"According to the inclusion criteria, only those aged between 55 and 85 are eligible for this trial. In comparison, there are 24 studies that accept participants below 18 years of age, while 533 trials encompass people over 65." - Anonymous Online Contributor
To which demographic does this research opportunity extend?
"To be considered for admission to this trial, applicants must have mild cognitive impairment and fall between the ages of 55 and 85. Approximately 60 participants will ultimately be selected." - Anonymous Online Contributor
Is there availability to participate in this medical trial?
"Affirmative. According to clinicaltrials.gov, this research endeavor is actively recruiting participants since April 14th 2018 and was last updated on January 28th 2022. 60 individuals are needed from one medical centre for the trial's completion." - Anonymous Online Contributor
How many individuals are partaking in this experiment?
"Affirmative. Clinicaltrials.gov states that this trial is actively recruiting, having been originally posted on April 14th 2018 and last updated January 28th 2022. In total 60 patients are necessary from 1 site to fulfil the requirements of the study." - Anonymous Online Contributor